CD30 is a biomarker of transformed stem cells
- Authors: Melikhova V.S.
- Issue: Vol 1, No 2 (2006)
- Pages: 19-19
- Section: Cell technology
- URL: https://genescells.ru/2313-1829/article/view/181626
- DOI: https://doi.org/10.23868/gc181626
- ID: 181626
Cite item
Open Access
Access granted
Full Text
About the authors
V. S. Melikhova
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Draper J.S., Smith К., Gokhale P. et al., Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004; 22:53-4.
- Maitra A., Arking D.E., Shivapurkar N. et al. Genomic alterations in cultured human embryonic stem cells. Nature Genetics 2005; 37:1099-103.
- Durkop H., Latza U„ Hummel M. et al. Molecular cloning and expression of a new memberofthe nerve growth factor receptor family that is characteristics for Hodgkin"s disease. Cell 1992; 68: 421-7.
- Pera M.F., Bennet W., Cerretti D.P. et al. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumours. Lab. Invest. 1997; 76: 497-504.
- Amit M„ Carpenter M.K., Inokuma M.S. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 2000; 227: 271-8.
Supplementary files
